摘要
Abstract
Objective To explore the efficacy and safety of five thymus peptide in patients with stable severe chronic ob-structive pulmonary disease. Methods In our hospital, 84 patients with stable severe chronic obstructive pulmonary disease were randomly divided into the observation group of 42 cases, 42 cases in the control group. The control group patients with stable se-vere chronic COPD treatment, observation of thymus in the conventional treatment based on the treatment of five patients of pep-tide. Evaluation of treatment of 2 groups of patients after lung function, heart rate and blood gas indexes in improving effect, and the incidence of adverse reactions were observed and statistics of 2 groups of patients after clinical treatment. Results After the treatment, the patients in the observation group were FVC, FFV1% , MEF50% index mean value is higher than that of the control group (P < 0. 05); in PaO 2 , SaO 2 and HR indicators, compared 2 groups of patients before treatment were increased (P < 0. 05), but the patients in the observation group were higher than those of the control group increased (P < 0. 05). Observe the complications of nausea and vomiting, abdominal pain, headache, decreased appetite and groups of patients with clinical treatment after the total incidence was 23. 81% , 21. 43% in the control group, the 2 groups, no significant difference (P < 0. 05). Conclusion The clini-cal effect of the treatment of five thymus peptide can effectively improve the stability of severe chronic obstructive pulmonary disease, and the security is good, worthy of clinical popularization and application.关键词
慢性阻塞性肺疾病/稳定期/重度/胸腺五肽Key words
chronic obstructive pulmonary disease/stable stage/severe/thymus peptide five分类
医药卫生
